乳糜微粒处理内皮细胞的细胞外小泡驱动巨噬细胞炎症。

IF 7.4 1区 医学 Q1 HEMATOLOGY
Anna Tilp, Dimitris Nasias, Andrew L Carley, Min Young Park, Ashley Mooring, Munichandra Babu Tirumalasetty, Nada A Abumrad, Yang Wang, Qing Robert Miao, E Douglas Lewandowski, José O Alemán, Ira J Goldberg, Ainara G Cabodevilla
{"title":"乳糜微粒处理内皮细胞的细胞外小泡驱动巨噬细胞炎症。","authors":"Anna Tilp, Dimitris Nasias, Andrew L Carley, Min Young Park, Ashley Mooring, Munichandra Babu Tirumalasetty, Nada A Abumrad, Yang Wang, Qing Robert Miao, E Douglas Lewandowski, José O Alemán, Ira J Goldberg, Ainara G Cabodevilla","doi":"10.1161/ATVBAHA.125.322712","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Movement of circulating lipids into tissues and arteries requires transfer across the endothelial cell (EC) barrier. This process allows the heart to obtain fatty acids, its chief source of energy, and apoB-containing lipoproteins to cross the arterial endothelial barrier, leading to cholesterol accumulation in the subendothelial space. Multiple studies have established elevated postprandial TRLs (triglyceride-rich lipoproteins) as an independent risk factor for cardiovascular disease. We explored how chylomicrons affect ECs and transfer their fatty acids across the EC barrier.</p><p><strong>Methods: </strong>We had reported that media from chylomicron-treated ECs lead to lipid droplet formation in macrophages. To determine the responsible component of this media, we assessed whether removing the extracellular vesicles (EVs) would obviate this effect. EVs from control and treated cells were then characterized by protein, lipid, and microRNA content. We also studied the EV-induced transcription changes in macrophages and ECs and whether knockdown of SR-BI (scavenger receptor-BI) altered these responses. In addition, using chylomicrons labeled with [<sup>13</sup>C]oleate, we studied the uptake and release of this labeled by ECs.</p><p><strong>Results: </strong>Chylomicron treatment of ECs led to an inflammatory response that included production of EVs that drove macrophage lipid droplet accumulation. The EVs contained little free fatty acids and triglycerides, but abundant phospholipids and diacylglycerols. In concert with this, [<sup>13</sup>]C labeled chylomicron triglycerides exited ECs primarily in phospholipids. EVs from chylomicron-treated versus untreated ECs were larger, more abundant, and contained specific microRNAs. Treatment of macrophages and naive ECs with media from chylomicron-treated ECs increased expression of inflammatory genes.</p><p><strong>Conclusions: </strong>EC chylomicron metabolism produces EVs that increase macrophage inflammation and create LDs. Media containing these EVs also increases EC inflammation, illustrating an autocrine inflammatory process. Fatty acids within chylomicron triglycerides are converted to phospholipids within EVs. Thus, EC uptake of chylomicrons constitutes an important pathway for vascular inflammation and tissue lipid acquisition.</p>","PeriodicalId":8401,"journal":{"name":"Arteriosclerosis, Thrombosis, and Vascular Biology","volume":" ","pages":""},"PeriodicalIF":7.4000,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Extracellular Vesicles From Chylomicron-Treated Endothelial Cells Drive Macrophage Inflammation.\",\"authors\":\"Anna Tilp, Dimitris Nasias, Andrew L Carley, Min Young Park, Ashley Mooring, Munichandra Babu Tirumalasetty, Nada A Abumrad, Yang Wang, Qing Robert Miao, E Douglas Lewandowski, José O Alemán, Ira J Goldberg, Ainara G Cabodevilla\",\"doi\":\"10.1161/ATVBAHA.125.322712\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Movement of circulating lipids into tissues and arteries requires transfer across the endothelial cell (EC) barrier. This process allows the heart to obtain fatty acids, its chief source of energy, and apoB-containing lipoproteins to cross the arterial endothelial barrier, leading to cholesterol accumulation in the subendothelial space. Multiple studies have established elevated postprandial TRLs (triglyceride-rich lipoproteins) as an independent risk factor for cardiovascular disease. We explored how chylomicrons affect ECs and transfer their fatty acids across the EC barrier.</p><p><strong>Methods: </strong>We had reported that media from chylomicron-treated ECs lead to lipid droplet formation in macrophages. To determine the responsible component of this media, we assessed whether removing the extracellular vesicles (EVs) would obviate this effect. EVs from control and treated cells were then characterized by protein, lipid, and microRNA content. We also studied the EV-induced transcription changes in macrophages and ECs and whether knockdown of SR-BI (scavenger receptor-BI) altered these responses. In addition, using chylomicrons labeled with [<sup>13</sup>C]oleate, we studied the uptake and release of this labeled by ECs.</p><p><strong>Results: </strong>Chylomicron treatment of ECs led to an inflammatory response that included production of EVs that drove macrophage lipid droplet accumulation. The EVs contained little free fatty acids and triglycerides, but abundant phospholipids and diacylglycerols. In concert with this, [<sup>13</sup>]C labeled chylomicron triglycerides exited ECs primarily in phospholipids. EVs from chylomicron-treated versus untreated ECs were larger, more abundant, and contained specific microRNAs. Treatment of macrophages and naive ECs with media from chylomicron-treated ECs increased expression of inflammatory genes.</p><p><strong>Conclusions: </strong>EC chylomicron metabolism produces EVs that increase macrophage inflammation and create LDs. Media containing these EVs also increases EC inflammation, illustrating an autocrine inflammatory process. Fatty acids within chylomicron triglycerides are converted to phospholipids within EVs. Thus, EC uptake of chylomicrons constitutes an important pathway for vascular inflammation and tissue lipid acquisition.</p>\",\"PeriodicalId\":8401,\"journal\":{\"name\":\"Arteriosclerosis, Thrombosis, and Vascular Biology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":7.4000,\"publicationDate\":\"2025-10-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Arteriosclerosis, Thrombosis, and Vascular Biology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1161/ATVBAHA.125.322712\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arteriosclerosis, Thrombosis, and Vascular Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/ATVBAHA.125.322712","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:循环脂质进入组织和动脉需要通过内皮细胞(EC)屏障转移。这一过程允许心脏获得脂肪酸(其主要能量来源)和含载脂蛋白的脂蛋白,以穿过动脉内皮屏障,导致胆固醇在内皮下空间积聚。多项研究已经证实餐后trl(富含甘油三酯的脂蛋白)升高是心血管疾病的独立危险因素。我们探讨了乳糜微粒如何影响EC并将其脂肪酸通过EC屏障转移。方法:我们已经报道了乳糜微粒处理的内皮细胞培养基导致巨噬细胞形成脂滴。为了确定这种培养基的作用成分,我们评估了去除细胞外囊泡(EVs)是否会消除这种影响。然后通过蛋白质、脂质和microRNA含量对对照细胞和处理细胞的ev进行表征。我们还研究了ev诱导巨噬细胞和内皮细胞的转录变化,以及SR-BI(清除受体bi)的敲低是否会改变这些反应。此外,我们利用[13C]油酸酯标记的乳糜微粒,研究了ECs标记的油酸酯的摄取和释放。结果:乳糜微粒处理ECs导致炎症反应,包括产生驱动巨噬细胞脂滴积聚的ev。游离脂肪酸和甘油三酯含量低,磷脂和二酰基甘油含量高。与此相一致的是,bbbbc标记的乳糜微粒甘油三酯主要在磷脂中退出ec。乳糜微粒处理的ev比未处理的ev更大,更丰富,并且含有特异性的microrna。用乳糜微粒处理的巨噬细胞和未处理的内皮细胞培养基处理后,炎症基因的表达增加。结论:EC乳糜微粒代谢产生的ev可增加巨噬细胞炎症并产生ld。含有这些ev的介质也会增加EC炎症,说明了自分泌炎症过程。乳糜微粒甘油三酯中的脂肪酸在ev内转化为磷脂。因此,乳糜微粒的EC摄取是血管炎症和组织脂质获取的重要途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Extracellular Vesicles From Chylomicron-Treated Endothelial Cells Drive Macrophage Inflammation.

Background: Movement of circulating lipids into tissues and arteries requires transfer across the endothelial cell (EC) barrier. This process allows the heart to obtain fatty acids, its chief source of energy, and apoB-containing lipoproteins to cross the arterial endothelial barrier, leading to cholesterol accumulation in the subendothelial space. Multiple studies have established elevated postprandial TRLs (triglyceride-rich lipoproteins) as an independent risk factor for cardiovascular disease. We explored how chylomicrons affect ECs and transfer their fatty acids across the EC barrier.

Methods: We had reported that media from chylomicron-treated ECs lead to lipid droplet formation in macrophages. To determine the responsible component of this media, we assessed whether removing the extracellular vesicles (EVs) would obviate this effect. EVs from control and treated cells were then characterized by protein, lipid, and microRNA content. We also studied the EV-induced transcription changes in macrophages and ECs and whether knockdown of SR-BI (scavenger receptor-BI) altered these responses. In addition, using chylomicrons labeled with [13C]oleate, we studied the uptake and release of this labeled by ECs.

Results: Chylomicron treatment of ECs led to an inflammatory response that included production of EVs that drove macrophage lipid droplet accumulation. The EVs contained little free fatty acids and triglycerides, but abundant phospholipids and diacylglycerols. In concert with this, [13]C labeled chylomicron triglycerides exited ECs primarily in phospholipids. EVs from chylomicron-treated versus untreated ECs were larger, more abundant, and contained specific microRNAs. Treatment of macrophages and naive ECs with media from chylomicron-treated ECs increased expression of inflammatory genes.

Conclusions: EC chylomicron metabolism produces EVs that increase macrophage inflammation and create LDs. Media containing these EVs also increases EC inflammation, illustrating an autocrine inflammatory process. Fatty acids within chylomicron triglycerides are converted to phospholipids within EVs. Thus, EC uptake of chylomicrons constitutes an important pathway for vascular inflammation and tissue lipid acquisition.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
15.60
自引率
2.30%
发文量
337
审稿时长
2-4 weeks
期刊介绍: The journal "Arteriosclerosis, Thrombosis, and Vascular Biology" (ATVB) is a scientific publication that focuses on the fields of vascular biology, atherosclerosis, and thrombosis. It is a peer-reviewed journal that publishes original research articles, reviews, and other scholarly content related to these areas. The journal is published by the American Heart Association (AHA) and the American Stroke Association (ASA). The journal was published bi-monthly until January 1992, after which it transitioned to a monthly publication schedule. The journal is aimed at a professional audience, including academic cardiologists, vascular biologists, physiologists, pharmacologists and hematologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信